Toggle navigation
Home
Search
Services
Blog
Contact
About
Role of Deadenylation in Mrna Decay
Zubiaga, Ana M.
Harvard University, Boston, MA, United States
Search grants from Ana Zubiaga
Search grants from Harvard University
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Publications
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
A Longitudinal Study of Gender Nonconformity in Prepubescent Children
Core A: Administrative Core
Preventive Health Services
SPF SIG Grant Program
Training in Sensorimotor Neuroplasticity
Recently added grants:
Mechanisms linking dietary fiber, the microbiome, and satiety
Reversal of Opioid-Induced Pathological Neuroplasticity Through Timed Electrical Stimulation
Mechanisms of translational output control in pancreatic cancer
Identifying Novel Therapeutics for High Risk Medulloblastoma Patients
Implication of Galectin-3 to regulate Graft vs. Host Disease (GvHD) and Graft vs. Tumor (GvT) Responses
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
1F32GM014669-01
Application #
3046243
Study Section
Biological Sciences 2 (BIOL)
Project Start
1992-01-09
Project End
Budget Start
1991-08-01
Budget End
1992-07-31
Support Year
1
Fiscal Year
1991
Total Cost
Indirect Cost
Institution
Name
Harvard University
Department
Type
Schools of Medicine
DUNS #
082359691
City
Boston
State
MA
Country
United States
Zip Code
02115
Related projects
NIH 1992
F32 GM
Role of Deadenylation in Mrna Decay
Zubiaga, Ana M. / Harvard University
NIH 1991
F32 GM
Role of Deadenylation in Mrna Decay
Zubiaga, Ana M. / Harvard University
Publications
Zubiaga, A M; Belasco, J G; Greenberg, M E
(1995)
The nonamer UUAUUUAUU is the key AU-rich sequence motif that mediates mRNA degradation.
Mol Cell Biol 15:2219-30
Comments
Be the first to comment on Ana Zubiaga's grant